Revenue
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Arcadia Biosciences, Inc. (RKDA)
Price$0.4648Cached quote
Net income
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.9M | $5.0M | $4.5M | $7.4M | $6.8M | $8.0M | $1.2M | $1.5M | $4.0M | $3.2M | $5.4M | $7.0M |
| Gross profit | $1.8M | $2.1M | $2.3M | $1.3M | −$1.9M | $2.8M | — | — | $3.7M | $2.3M | $4.5M | $5.0M |
| Gross margin | 36.23% | 41.27% | 51.19% | 17.75% | −28.44% | 35.29% | — | — | 92.97% | 71.93% | 83.52% | 71.40% |
| Research & development | $9,000 | $53,000 | $64,000 | $1.5M | $3.9M | $8.0M | $7.1M | $6.1M | $7.4M | $8.7M | $9.0M | $10.0M |
| Operating expenses | $7.4M | $8.7M | $10.6M | $21.4M | $42.3M | $20.8M | $20.6M | $18.3M | $18.3M | $21.8M | $21.0M | $22.1M |
| Operating income | −$2.5M | −$3.6M | −$6.1M | −$14.0M | −$35.5M | −$12.8M | −$19.4M | −$16.9M | −$14.3M | −$18.6M | −$15.6M | −$15.2M |
| Operating margin | −51.46% | −72.31% | −137.00% | −188.82% | −523.98% | −159.05% | −1,657.91% | −1,152.32% | −355.56% | −584.07% | −287.46% | −217.03% |
| EBITDA | −$2.5M | −$3.6M | −$6.0M | −$13.5M | −$34.5M | −$12.1M | −$19.2M | −$16.7M | −$14.0M | −$18.3M | −$15.3M | −$14.8M |
| EBITDA margin | −50.80% | −71.16% | −134.51% | −182.37% | −508.57% | −150.81% | −1,641.32% | −1,141.80% | −348.63% | −574.53% | −282.03% | −211.90% |
| Net income | −$2.3M | −$7.0M | −$14.0M | −$15.4M | −$14.7M | −$4.7M | −$28.8M | −$13.5M | −$15.7M | −$19.6M | −$18.0M | −$18.3M |
| Net profit margin | −48.15% | −139.50% | −313.90% | −207.28% | −216.22% | −57.94% | −2,464.07% | −920.77% | −390.14% | −615.56% | −331.66% | −262.66% |
| Basic EPSper basic share | -$1.71 | -$5.17 | -$11.29 | -$25.65 | -$27.56 | -$18.80 | -$181.20 | -$143.20 | -$291.20 | -$354.00 | -$584.00 | -$8,568.00 |
| Diluted EPSper diluted share | -$1.71 | -$5.17 | -$11.29 | -$25.65 | -$27.56 | -$18.80 | -$181.20 | -$143.20 | -$291.20 | -$354.00 | -$584.00 | -$8,568.00 |
Owners
Reported shareholders
4.05%of listed shares
HRT FINANCIAL LP88.39K shares · Jun 30, 2026
View holders
| Holder | % owned |
|---|---|
HRT FINANCIAL LP | 4.05%88.39K shares |
CITADEL ADVISORS LLC | 1.09%23.74K shares |
Virtu Financial LLC | 1.00%21.79K shares |
GEODE CAPITAL MANAGEMENT, LLC | 0.74%16.14K shares |
XTX Topco Ltd | 0.71%15.48K shares |
StoneX Group Inc. | 0.63%13.68K shares |
STATE STREET CORP | 0.56%12.15K shares |
JANE STREET GROUP, LLC | 0.47%10.25K shares |
VANGUARD CAPITAL MANAGEMENT LLC | 0.44%9.64K shares |
Schaefer Thomas J. | ≈0.13%2.82K shares |
Kawakami Mark | ≈0.12%2.68K shares |
SBI Securities Co., Ltd. | <0.01%120 shares |
TD Waterhouse Canada Inc. | <0.01%70 shares |
UBS Group AG | <0.01%35 shares |
GROUP ONE TRADING LLC | <0.01%18 shares |
MORGAN STANLEY | <0.01%2 shares |
SOUTHERN MICHIGAN BANK & TRUST | <0.01%2 shares |
Caitong International Asset Management Co., Ltd | <0.01%1 shares |
Percentages use 2.18M shares of this listed class outstanding on Jun 30, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Feb 3, 2025Form 4 | Kawakami MarkChief Financial Officer | BuyCommon Stock | 700 | $2.49 | $1.7K | 2.7K |
| Feb 3, 2025Form 4 | Schaefer Thomas J.Chief Executive Officer | BuyCommon Stock | 700 | $2.49 | $1.7K | 2.8K |
| Aug 1, 2024Form 4 | Kawakami MarkChief Financial Officer | BuyCommon Stock | 700 | $2.06 | $1.4K | 2.0K |
| Aug 1, 2024Form 4 | Schaefer Thomas J.Chief Executive Officer | BuyCommon Stock | 700 | $2.06 | $1.4K | 2.1K |